Atalaya Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Atalaya Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$8K	–	224
2023 Q1	$8K	Hold	100,000	–	–	﹤0.01%	166
2022 Q4	$15K	Hold	100,000	–	–	﹤0.01%	174
2022 Q3	$18K	Hold	100,000	–	–	﹤0.01%	247
2022 Q2	$15K	Hold	100,000	–	–	﹤0.01%	260
2022 Q1	$37K	Hold	100,000	–	–	﹤0.01%	296
2021 Q4	$96K	Hold	100,000	–	–	0.01%	282
2021 Q3	$87K	Buy	+100,000	New	+$130K	0.01%	224

Atalaya Capital Management's ORIAW Position: Q2 2023 in Review

Atalaya Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 100,000 shares — an estimated $8K sold.

Atalaya Capital Management first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $96K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Atalaya Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Atalaya Capital Management sold 100,000 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $8K.
Atalaya Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
Atalaya Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $96K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Atalaya Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.